NIDDK - Targeting Inflammation and Salsalate as a Novel Therapy for Diabetic Neuropathy

Targeting Inflammation and Salsalate as a Novel Therapy for Diabetic Neuropathy

Dr. Eva Feldman jointly received this NIH grant with Dr. Rodica Pop-Busui (R01DK107956) to run a clinical trial in type 1 diabetes patients. They are testing the effectiveness of a compound called salsalate on the progression of neuropathy.